top button
    Got Questions

Global IoT Summit 2018
Oct 31, 2018
The Leela Palace, Bangalore

    Connect to us
      Facebook Login
      Site Registration Why to Join

Facebook Login
Site Registration

U.S. Retail Clinics Market Trends Companies In-depth Analysis, Business Strategies, and Growth Rate

0 votes

Retail clinics are a convenient way for patients to visit a walk-in health care clinic. These clinics are located inside retail stores such as supermarkets and department stores. They are sometimes referred to as convenient care clinics. These clinics offer benefits similar to that offered by traditional clinics. They are usually staffed by nurses and physician assistants. Retail clinics provide medical services such as treatment for flu, cold, dehydration, fever, cough, diagnostic services, vaccination, laboratory tests, physiotherapy, and treatment for injuries.

Report overview @

The first retail clinic was opened in 2001 in Minnesota. Retail clinics are experiencing a commendable growth due to patient preference for convenient care options, cost effectiveness, easy accessibility, and multiple services offered. Furthermore, factors contributing to the growth of this market are increase in shortage of primary care physician, growth in health care expenditures, and rise in incidence rate of communicable diseases.

Also, several retail clinics are providing treatment and management for chronic diseases such as asthma, diabetes, hypertension, and high cholesterol disorders. This factor is likely to propel the market growth during the forecast period. However, retail clinics are a secondary choice for many patients, which limits customer volume in these clinics. Low patient population visiting retail clinics and regulations in some countries are impacting the growth of the retail clinics market.

Request PDF Sample of Retail Clinics Market Report @

The retail clinics market can be segmented on the basis of location, types of suppliers, and geography. Based on location, retail clinics are further segmented into stores, malls, and other retail locations. Geographically, this market is further divided into North America, Europe, Asia Pacific, Latin America, and Middle East Asia and Africa. North America accounted for a significant growth rate due to factors such as large population base turning toward convenience care, adoption of electronic medical and chart records, and introduction of digital tools.

According to Centers for Disease Control and Prevention (CDC), about 18 million adults suffered from asthma in 2012, which was one of the factors that had driven the growth of the retail clinics market. South East Asia, Middle East, and Latin America are projected to be the potential markets in the near future due to higher adoption rate of retail clinics, rise of disposable income, increase in disease burden, shortage of physicians, and ease of usage. Star Dental Care, a U.S. based institute, is aiming to open up retail dental clinics in India by 2017, which is estimated to enhance the growth of the market in this country.

Buy Now “Retail Clinics Market” Research Report @

Major players operating in the retail clinics market include Kroger, Rite Aid, Doctors Care, Clear Balance, CVS Health’s MinuteClinic, NEXtCARE, RediClinic, Target Brands, Inc., The Little Clinic, U.S. HealthWorks, Inc., Urgent Care MSO, LLC, and Walgreen Co. Growth of retail clinics and the companies are related to initiatives aimed at patient’s satisfaction. With growing experience, companies are expanding their services and experiment with new methods such as telemedicine integration, point-of-care technologies, and offering new services. For example, Minute Clinic (CVS) launched a digital tool in May 2016 which helped patients to estimate the wait time at several locations.

More Trending Reports by Transparency Market Research –

Hearing Aids Market:

Global Wound Healing Market:

posted 4 days ago by Bella Watson

  Promote This Article
Facebook Share Button Twitter Share Button Google+ Share Button LinkedIn Share Button Multiple Social Share Button

Related Articles
0 votes

Pets are the proven true companies to humans. Since years, pets are considered as family and this association with them has grown than ever before. People now are willing to spend huge sum of money in up keeping of their pets. Thus, with the growing pet population across the globe has augmented growth in various veterinary services. Moreover, one of the major market in which the demand is rising is veterinary endoscopes market. Pets usually face gastrointestinal issues leading to gastrointestinal diseases in some cases. Due to this rise, the demand in the veterinary endoscopes market has increased significantly globally. Endoscopes help in examining esophagus, abdomen, bladder, and other internal organs.

Pets being such as important part, the need to analysis growth prospects in this market are important. In the report published by Transparency Market Research on the global veterinary endoscopes market, gives crucial information related to the growth of this market. Revenue growth rate for the global veterinary endoscopes is estimated to be 6.7% over the projected tenure from 2017 to 2025. If the market rises at this rate revenue generation will increase to US$ 728.1 billion by the end of 2025. This figure is substantially higher than US$405.1 million earned in 2016, thus creating an incremental opportunity of approximately US$ 323 million over the forecast tenure. With high revenue generation opportunity, players operating in this market are likely to generate high profits in the coming years.

Request PDF Sample of Veterinary Endoscopes Market Trends Report @

Prominent players analyzed in the global veterinary endoscopes market report by TMR include Olympus Corporation, Harvard Bioscience Infiniti Medical, KARL STORZ SE & Co. KG, Fujifilm Holdings Corporation,  and Richard Wolf GmbH, STERIS plc. Leading players are using new and advanced business development strategies to get larger share in the market. New product launches, higher investment in research and development, they are also engaged in establishing partnership through collaboration and acquisition.

Importance of Internal Examination has Boosted Gastrointestinal Endoscopy Procedures

Application of veterinary endoscopes is widely seen in diagnostics segment. Increasing gastrointestinal issues among pets and difficulty faced while finding the actual cause of the disease without the internal examination has fueled demand for veterinary endoscopes. In terms of procedure, gastrointestinal segment is leading the market. Stats as per the Journal of Veterinary Medicine and Animal Health state that the occurrences of gastrointestinal parasitic infection in tethered animals are extremely high.  Moreover, the gastrointestinal parasitic infection has affected large number of cattle across the globe. Thus, with the increasing share of the gastrointestinal endoscopy procedure over bronchoscopy, laparoscopy, cystoscopy, and otoscopy segments is likely to drive growth in the global veterinary endoscopes market.

Buy Now “Veterinary Endoscopes Market Trends” Research Report @

Growing Preference for Companion Pets Made North America a Key Region for Veterinary Endoscopes Market

With respect to regional growth, importance and use of veterinary endoscopes is high in North America due to rising companion animals in the region. Moreover, developed and advanced veterinary healthcare infrastructure and increasing pet healthcare insurance has made the region a leading market for the growth of veterinary endoscopes. Stats based on American Society for the Prevention of Cruelty to Animals (ASPCA) reveal that every year nearly 6.5 million companion animals arrive at the US animal shelters nationwide, which increases the use of veterinary endoscopes to completely analyze these pets. This factor has also augmented the growth in the global veterinary endoscopes market.

On the other hand, Asia Pacific is also considered a key region for the growth of the global veterinary endoscopes market. Growing preference for companion pets is the major reason behind the growth of veterinary endoscopes in this region.

More Trending Reports by Transparency Market Research –

Non-invasive Prenatal Testing Market:—says-tmr-300865294.html

Global Wound Healing Market:

0 votes

The automated external defibrillators (AED) market has seen a robust impetus from the public access to defibrillation programs to improve outcomes in out-of-hospital cardiac arrest. Continuous advances in operators’ parameters and in devices have opened new windows to responders and healthcare personnel in the management of such patients. Transparency Market Research (TMR) observes that the growing utility of the technology for the timely defibrillation of shockable rhythms has underpinned the expansion of the market over the years. The devices are seeing a widespread uptake in pre?hospital settings. 

Relentless efforts by medical device manufacturers to unveil automated external defibrillators with high reliability and better effectiveness and safety profiles have helped them strengthen their foothold, notes players. Growing investments by several top players have focused on attaining the optimal point of cost-benefit trade-off to attract consumers and healthcare providers. Further, numerous players in recent years have struck strategic alliances to consolidate their geographic position in the automated external defibrillators market. Some of the well-entrenched players include Philips (Koninklijke Philips), Nihon Kohden, Asahi Kasei, GE Healthcare, and Physio-Control Corporation.

Request PDF Sample of Automated External Defibrillators Market Report @

Growing Feasibility of Public-access AEDs Boost Prospects 

The growing health concern of out?of?hospital cardiac arrest, especially in some developed nations around the world, is a key factor driving the market. The growing feasibility of public-access AED has helped catalyze prospects in the market. The global automated external defibrillators market was worth US$1213.40 mn in 2016. Clocking an impressive CAGR of 15.8% from 2017 to 2025, the market is expected to reach US$4473.40 by the end of this period. 

Medical device makers in the automated external defibrillators market are reaping consistent streams of revenues from the prevalence of life-threatening cardiac diseases such as cardiac arrhythmias. A great deal of the demand is filliped by rapidly growing aging populations in developed nations, such as Japan. In such regions, the deployment of public?access automated external defibrillators (PAD) has grown substantially over the years.

Buy Now “Automated External Defibrillators Market” Research Report @

Improving Paradigm of Cardiac Care in Developing Markets Makes Strong Proposition of Out-Of-Hospital Defibrillation 

Increased focus in recent years over community?based PAD programs has expanded the window of opportunities in the automated external defibrillators market. However, cost-effectiveness of such programs aside, their low benefit is undoubtedly concern, proving to be a challenge for proponents of PAD. Healthcare providers must take due notice of the widening gap between the occurrence of out?of?hospital cardiac arrests and public access to automated external defibrillators. In addition to out-of-hospital settings, device makers in the automated external defibrillators market are earning revenues from the uptake in in-hospital cardiac arrest patients.

The significant survival rate of bystander cardiopulmonary resuscitation around the world is also a key aspect of the expanding automated external defibrillators market. Growing disposable incomes and improving paradigm of cardiac care in developing countries have catalyzed the uptake of automated external defibrillators in in-hospital settings. Growing awareness about the prevalence and mortality of cardiac arrest has also created a viable market for automated external defibrillators. 

More Trending Reports by Transparency Market Research –

Liquid Biopsy Market:—says-tmr-300864391.html

HIV/AIDS Diagnostics Market:—says-tmr-300827872.html

0 votes

The global heparin market is expected to become progressively competitive over the forthcoming years. This is due to the strengthening position of the leading market players in the global market for heparin. Several initiatives have been taken by the leading market players to retain their strong foothold over the market. Intensive research and development along with effective marketing hacks have been the key highlights of the business strategy of the leading market players. Furthermore, the market players have gained commendable revenues by dispelling their products through multiple distribution channels. It is anticipated that the top market players would keep recalibrating their approach to match the needs and trends of the market.

An analysis of the regional market players reveals that these players are not present in huge numbers; in fact, only a handful of regional or local market players exist in the market. The entry of new players into the global market for heparin is inhibited by the strong position of the existing players. The leading market players are expected to capture the smaller players over the coming years. This would further fortify the position of the top market players and make the market increasingly consolidated. Some of the key players in the global market for heparin are Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Fresenius SE & Co. KGaA, LEO Pharma A/S, Sanofi, Pfizer, Inc., Aspen, B. Braun Melsungen AG, Baxter International Inc., and Syntex S.A.

Request PDF Sample of Heparin Market Report @

The global market for heparin is expected to expand at a sturdy CAGR of 6.20% over the period between 2017 and 2025, finds Transparency Market Research (TMR). The global market was valued at US$10.1 bn in 2017 and is expected to accumulate revenues worth US$16.3 bn by 2025-end.

Rising Incidence of Thromboembolic Disorders Drives Demand

The pharmaceutical industry has been growing at a starry rate over the past decade, and this has given an impetus to the growth of the global market for heparin. Heparin is most commonly used to treat coagulation of blood, and the rising incidence of such disorders could give an impetus to the global market. Furthermore, thromboembolic disorders have also become more common than a few years ago. This is also an important standpoint with regards to the growth of the global market for heparin. The food and drug administration (FDA) of the United States has also stipulated several regulations that have favored the growth of the global market for heparin. It is anticipated that the market for heparin would tread along a positive growth track due to the efforts of governments and the pharmaceutical industry.

Enquiry for Discount on “Heparin Market ” Report @

Adverse Effects of Heparin to Hamper Growth

The global market for heparin is reaping benefits from the advancements in the pharmaceutical industry, but limited bioavailability of heparin is projected to hamper market growth. Furthermore, heparin is also believed to have side effects for humans, which is another hindrance to market growth. Protamine sulfate can be used as a substitute for heparin, thus, blocking the growth of the global market for heparin.

0 votes

3D Mammography Market: Introduction

  • Breast tomosynthesis, also known as 3D mammography, is the latest technology used for breast cancer screening. According to Hologic, its Hologic 3Dimensions™ Mammography System detect 20%-65% more invasive cancer than 2D mammography systems.
  • 3D mammography allows visualization in thin slices, as tomosynthesis eliminates overlap of normal tissue, thereby decreasing inaccurate readings

Key Drivers of Global 3D Mammography Market

  • The global 3D mammography market is likely to be driven by the rise in prevalence of breast cancer. Incidences of breast cancer are higher in developed countries while mortality rate is higher in lesser-developed and poor countries due to late diagnosis and availability of necessary health care and treatment facilities. Therefore, rise in prevalence of breast cancer in developed and developing countries across the globe is anticipated to drive the global 3D mammography market.
  • According to the Centers for Disease Control and Prevention (CDC), breast cancer is the most common type of cancer in women. In 2017, breast cancer accounted for 30% of all types of newly diagnosed cancer among women.
  • Increase in breast cancer research activities is driving the demand for 3D mammography systems. Moreover, 3D mammography systems are used for breast research to acquire a comprehensive understanding. This, in turn, is contributing to the growth of the global 3D mammography market.

Get a Glimpse of the In-Depth Analysis through our Comprehensive 3D Mammography Market Brochure

  • There is a rise in trend of rental contract agreement of 3D mammography systems. Rental contract agreements allow end-users to pay a certain amount per 3D mammogram performed using 3D mammography systems installed free of cost by manufacturers. This helps low budget hospitals and diagnostic labs to adopt this advanced technology for breast imaging.
  • Public mammography screening has been introduced in several countries in recent years.  3D mammography systems are used in these public mammography screening programs to obtain maximum accuracy in detection of breast cancer.

North America to Hold Significant Share of Global 3D Mammography Market

  • North America was the leading market for 3D mammography systems in 2018 driven by the rise in the adoption of technologically advanced devices for breast imaging. Moreover, rise in prevalence of breast cancer in the geriatric population is expected to propel the market during the forecast period. Favorable reimbursement policies in the U.S. for mammography is anticipated to augment the market in the region during the forecast period.
  • According to the American Cancer Society, nearly 252,710 new cases of cancer were diagnosed in the U.S. in 2017 and the incidence rate is expected to increase substantially over the next few years
  • Asia Pacific is projected to be the fastest growing market for 3D mammography during the forecast period due to the improving health care infrastructure. Rise in the number of diagnostic centers is likely to fuel the growth of the global 3D mammography market in Asia Pacific.

Expanding Operations in Future? To Get the Perfect Launch Ask for a Custom 3D Mammography Market Report

Key Players Operating in Global 3D Mammography Market

Major players in the global 3D mammography market are:

  • General Electric Company
  • Hologic, Inc.
  • Siemens
  • FUJIFILM Holdings America Corporation
  • Konica Minolta, Inc.
0 votes

In Vitro Toxicology Testing Market: Introduction

  • Toxicology or toxicity, also known as ‘the science of poisons,’ is a method of testing the opposing effects of any drug, chemical or other agent administered in the body. It, thus, analyses the adverse effects of various toxins on all living organisms.
  • In vitro toxicology testing does not make use of whole animals or whole organisms. It rather uses tissue slices, isolated organs, cell lines isolated primary cell cultures, explants cultures, and subcellular fractions such that of mitochondria and membranes.
  • In vitro toxicology testing also helps in determining the drug safety profile at an early stage, thus saving a considerable amount of time and resource investment

Report Overview @

To understand how our report can bring difference to your business strategy, Ask for a brochure

Key Drivers and Restraints of Global In Vitro Toxicology Testing Market

  • Scientific concerns over animal experiments have been raised in the field of toxicology testing. It entails problems such as difference between various test animals and resultant effects of toxicants, characterization of actions of these toxins on different animals, and categorization of test animals on the basis of their biology and effects of toxins.
  • Animal testing has been in effect since long; however, the implementation of in vitro toxicology testing is an alternative to animal testing. It is effective and harmless as compared to animal testing.
  • In vitro toxicology is cost effective and growing ethical concerns worldwide are expected to drive the in vitro toxicology market during the forecast period. Pharmaceutical companies are, thus, increasingly shifting their focus from animal testing to in vitro toxicology testing.

To Know the Scope of Our Report Get a Brochure on “In Vitro Toxicology Testing Market” here @

  • Advantages of in vitro toxicology testing over traditional methods of animal testing in terms of quick turnaround time and better sample control will also help the global market to grow at a rapid rate
  • Opposition to animal testing will have a major impact on the in vitro toxicology testing market, as animal testing will be reduced to a large extent

Cellular Assay Technology Segment to Lead Global In Vitro Toxicology Testing Market

  • In terms of technology, the global in vitro toxicology testing market can be divided into cellular assay, biochemical assay, in silica, and ex-vivo
  • In the present scenario, cellular assay methods are widely used by industries in safety assessment, risk evaluation, and toxicity testing. The cellular assay method is mainly used to elucidate mechanisms of toxicity in a drug and its effect on a cell or a tissue.

Pharmaceutical Industry Segment to Offer Growth Opportunities

  • Based on end-user, the global in vitro toxicology testing market can be categorized into cosmetics & household products, pharmaceutical industry, food industry, and chemicals industry
  • Pharmaceutical industry is estimated to be a highly lucrative segment. Pharmaceuticals play a major role in in vitro toxicology testing, as the test is to identify the toxicity of various chemical drugs and their effects on the human body. Chemicals are used in various products, which has a direct or indirect effect on the human body .Thus, in vitro toxicology can be useful in finding the toxic nature of such chemicals and their effects on the human body.

Pre Book “In Vitro Toxicology Testing Market” Research Report @

North America to Lead Global In Vitro Toxicology Testing Market

  • The global in vitro toxicology testing market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is a significant market for in vitro toxicology testing due to the presence of several key market players.
  • Substantial investments in research and development by various end-user segments in the region are anticipated to drive the global in vitro toxicology testing market in North America

Key Players Operating in Global In Vitro Toxicology Testing Market

Key players operating in the global in vitro toxicology testing market are:

  • Abbott Laboratories
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Cyprotex
  • Charles River Laboratories, Inc.
  • Covance, Inc.
  • Thermo Fisher Scientific, Inc.